Top Markets
Coin of the day
Hvsen Biotechnology Co., Ltd. Hvsen Biotechnology Co., Ltd.

Hvsen Biotechnology Co., Ltd.

300871
Rank in Stocks #11646
Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses... Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses on the global research, development, and manufacturing of macrolide active pharmaceutical ingredients (APIs) and finished drug products. The company's diverse product portfolio features tylvalosin, offered in both raw material form and various preparations, along with florfenicol preparations and a broader selection of other macrolide-based offerings. Additionally, Hvsen produces a range of veterinary pharmaceuticals, available as both raw ingredients and finished drugs, alongside traditional Chinese medicine extracts.
Share Price
$3.35
Last synced: 2026-08-28
Market Cap
$675.48M
Change (1 day)
0.26%
Change (1 year)
5.11%
Country
CN
Trade Hvsen Biotechnology Co., Ltd. (300871)

Category

Number of shares outstanding for Hvsen Biotechnology Co., Ltd. (300871)
Number of shares outstanding as of August 2026: 0
According to Hvsen Biotechnology Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Hvsen Biotechnology Co., Ltd. (300871) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
478.91M -
AU
396.00M -
US
- -
CH